Angiogenesis Inducing Agents
-
Subject Areas on Research
- Acidic stress promotes a glioma stem cell phenotype.
- An engineered vascular endothelial growth factor-activating transcription factor induces therapeutic angiogenesis in ApoE knockout mice with hindlimb ischemia.
- Angiogenesis and molecular biologic substaging in patients with stage I non-small cell lung cancer.
- Angiogenic, neurotrophic, and inflammatory system SNPs moderate the association between birth weight and ADHD symptom severity.
- Basic fibroblast growth factor expression following surgical delay of rat transverse rectus abdominis myocutaneous flaps.
- Circulating angiogenic factors and abnormal uterine artery Doppler velocimetry in the second trimester.
- Current insights on the biology and clinical aspects of VEGF regulation.
- Effect of low-fat diets on plasma levels of NF-κB-regulated inflammatory cytokines and angiogenic factors in men with prostate cancer.
- Evolving revascularization approaches for myocardial ischemia.
- Growth factors for therapeutic angiogenesis in peripheral arterial disease.
- Identification of sokotrasterol sulfate as a novel proangiogenic steroid.
- Improved Angiogenesis in Response to Localized Delivery of Macrophage-Recruiting Molecules.
- In mice with type 2 diabetes, a vascular endothelial growth factor (VEGF)-activating transcription factor modulates VEGF signaling and induces therapeutic angiogenesis after hindlimb ischemia.
- Inhibition of rat corneal angiogenesis by a nuclease-resistant RNA aptamer specific for angiopoietin-2.
- Modulation of circulating angiogenic factors and tumor biology by aerobic training in breast cancer patients receiving neoadjuvant chemotherapy.
- Molecular approaches for the treatment of atherosclerosis.
- Myocardial tissue elastic properties determined by atomic force microscopy after stromal cell-derived factor 1α angiogenic therapy for acute myocardial infarction in a murine model.
- Non-viral DNA delivery from porous hyaluronic acid hydrogels in mice.
- Phase II trial of infusional fluorouracil, irinotecan, and bevacizumab for metastatic colorectal cancer: efficacy and circulating angiogenic biomarkers associated with therapeutic resistance.
- Recombinant human platelet-derived growth factor-BB and beta-tricalcium phosphate (rhPDGF-BB/β-TCP): an alternative to autogenous bone graft.
- Responses of vascular endothelial cells to angiogenic signaling are important for tumor cell survival.
- Serum inter-alpha-trypsin inhibitor and matrix hyaluronan promote angiogenesis in fibrotic lung injury.
- Stimulation of endothelial cell prostacyclin release by retina-derived factors.
- The CXC chemokine cCAF stimulates precocious deposition of ECM molecules by wound fibroblasts, accelerating development of granulation tissue.
-
Keywords of People
- McLendon, Roger Edwin, Professor of Pathology, Pathology